Breast Cancer Tissue Array Containing Primary And Matched Metastatic Tumors (in Lymph Nodes) And Adjacent Normal Breast Tissue, 48 Casea/96 Cores|ヒト組織アレイ
掲載日情報：2015/08/07 現在Webページ番号：172937
US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Breast Cancer Tissue Array Containing Primary And Matched Metastatic Tumors (in Lymph Nodes) And Adjacent Normal Breast Tissue, 48 Casea/96 Cores)をご紹介します。
※ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
※ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
※本製品は研究用です。研究用以外には使用できません。
カートに商品を
追加しました。
追加しました。
ヒト組織アレイの価格
[在庫・価格 ：2024年05月17日 00時01分現在]
※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
| 詳細 | 商品名 |
|
文献数 | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Human, Breast Cancer, with 36 Matched Matastatic Breast Cancer and 12 Normal Tissue, 48cases/96cores, Tissue Array |
|
0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
[在庫・価格 ：2024年05月17日 00時01分現在]
※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
Human, Breast Cancer, with 36 Matched Matastatic Breast Cancer and 12 Normal Tissue, 48cases/96cores, Tissue Array
文献数： 0
- 商品コード：BRM961
- メーカー：USB
- 包装：1slide
- 価格：¥87,000
- 在庫：無(未発注)
- 納期：2～3週間 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。
- 法規制等：
| 説明文 | |||
|---|---|---|---|
| 法規制等 | |||
| 保存条件 | 室温,暗所保存 | 法規備考 | |
| 掲載カタログ |
|
||
| 製品記事 |
TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド |
||
| 関連記事 |
TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして |
||
カートに商品を
追加しました。
追加しました。
ヒト組織アレイの特長
| Microarray Panel: | Breast carcinoma metastatic tissue microarray, containing 48 cases of breast cancer, with 36 matched matastatic breast cancer and 12 normal tissue | |
|---|---|---|
| Cores: | 96 |
 |
| Cases: | 48 | |
| Layout: | 12 cols × 8 rows | |
| Core Diameter: | 1.5 mm | |
| Thickness: | 4 µm | |
| Quality Control: | H&E, IHC anti-Cytokeratin | |
| Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
|
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. | |
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H and E: Hematoxylin and Eosin stained tissue array slide.
カートに商品を
追加しました。
追加しました。
ヒト組織アレイの仕様表
| Pos | No. | Sex | Age | Organ | Pathology diagnosis | Grade | TNM | Type † |
|---|---|---|---|---|---|---|---|---|
| A1 | 1 | F | 29 | Breast | Invasive/infiltrating ductal carcinoma | III | T3N0M0 | Malignant |
| A2 | 2 | F | 35 | Breast | Invasive/infiltrating ductal carcinoma | II~III | T2N0M0 | Malignant |
| A3 | 3 | F | 80 | Breast | Intra-ductal carcinoma | I~II | T2N0M0 | Malignant |
| A4 | 4 | F | 45 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N0M0 | Malignant |
| A5 | 5 | F | 36 | Breast | Invasive/infiltrating ductal carcinoma | III | T2N0M0 | Malignant |
| A6 | 6 | F | 35 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N0M0 | Malignant |
| A7 | 7 | F | 57 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N0M0 | Malignant |
| A8 | 8 | F | 52 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N0M0 | Malignant |
| A9 | 9 | F | 38 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N0M0 | Malignant |
| A10 | 10 | F | 51 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N0M0 | Malignant |
| A11 | 11 | F | 43 | Breast | Intra-ductal carcinoma | I~II | T2N0M0 | Malignant |
| A12 | 12 | F | 38 | Breast | Invasive/infiltrating lobular carcinoma | II | T2N0M0 | Malignant |
| B1 | 13 | F | 29 | Breast | Uninvolved breast tissue of A1 | Normal | ||
| B2 | 14 | F | 35 | Breast | Uninvolved breast tissue of A2, hyperplasia | Normal | ||
| B3 | 15 | F | 80 | Breast | Uninvolved breast tissue of A3, no gland | Normal | ||
| B4 | 16 | F | 45 | Breast | Uninvolved breast tissue of A4 | Normal | ||
| B5 | 17 | F | 36 | Breast | Uninvolved breast tissue of A5 | Normal | ||
| B6 | 18 | F | 35 | Breast | Uninvolved breast tissue of A6 | Normal | ||
| B7 | 19 | F | 57 | Breast | Uninvolved breast tissue of A7, no gland | Normal | ||
| B8 | 20 | F | 52 | Breast | Uninvolved breast tissue of A8, no gland | Normal | ||
| B9 | 21 | F | 38 | Breast | Uninvolved breast tissue of A9, no gland | Normal | ||
| B10 | 22 | F | 51 | Breast | Uninvolved breast tissue of A10 | Normal | ||
| B11 | 23 | F | 43 | Breast | Uninvolved breast tissue of A11 | Normal | ||
| B12 | 24 | F | 38 | Breast | Uninvolved breast tissue of A12 | Normal | ||
| C1 | 25 | F | 63 | Breast | Invasive/infiltrating ductal carcinoma | II~III | T4N2M0 | Malignant |
| C2 | 26 | F | 60 | Breast | Invasive/infiltrating ductal carcinoma | II~III | T4N1M0 | Malignant |
| C3 | 27 | F | 47 | Breast | Invasive/infiltrating ductal carcinoma | II | T3N1M0 | Malignant |
| C4 | 28 | F | 50 | Breast | Invasive/infiltrating ductal carcinoma | II | T3N1M0 | Malignant |
| C5 | 29 | F | 52 | Breast | Invasive/infiltrating ductal carcinoma | II | T3N1M0 | Malignant |
| C6 | 30 | F | 54 | Breast | Invasive/infiltrating ductal carcinoma | II~III | T3N3M0 | Malignant |
| C7 | 31 | F | 43 | Breast | Invasive/infiltrating lobular carcinoma | II | T3N1M0 | Malignant |
| C8 | 32 | F | 54 | Breast | Invasive/infiltrating lobular carcinoma | II | T3N1M0 | Malignant |
| C9 | 33 | F | 45 | Breast | Invasive/infiltrating ductal carcinoma | II | T3N1M0 | Malignant |
| C10 | 34 | F | 68 | Breast | Invasive/infiltrating ductal carcinoma | II~III | T3N1M0 | Malignant |
| C11 | 35 | F | 46 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| C12 | 36 | F | 39 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| D1 | 37 | F | 63 | Lymph node | Lymph node metastasis of C01 | Metastasis | ||
| D2 | 38 | F | 60 | Lymph node | Lymph node metastasis of C02 | Metastasis | ||
| D3 | 39 | F | 47 | Lymph node | Lymph node metastasis of C03 | Metastasis | ||
| D4 | 40 | F | 50 | Lymph node | Lymph node metastasis of C04 | Metastasis | ||
| D5 | 41 | F | 52 | Lymph node | Lymph node metastasis of C05 | Metastasis | ||
| D6 | 42 | F | 54 | Lymph node | Lymph node metastasis of C06 | Metastasis | ||
| D7 | 43 | F | 43 | Lymph node | Lymph node metastasis of C07 | Metastasis | ||
| D8 | 44 | F | 54 | Lymph node | Lymph node metastasis of C08 | Metastasis | ||
| D9 | 45 | F | 45 | Lymph node | Lymph node metastasis of C09 | Metastasis | ||
| D10 | 46 | F | 68 | Lymph node | Lymph node metastasis of C10 | Metastasis | ||
| D11 | 47 | F | 46 | Lymph node | Lymph node metastasis of C11 | Metastasis | ||
| D12 | 48 | F | 39 | Lymph node | Lymph node metastasis of C12 | Metastasis | ||
| E1 | 49 | F | 35 | Breast | Invasive/infiltrating lobular carcinoma | I | T2N1M0 | Malignant |
| E2 | 50 | F | 40 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| E3 | 51 | F | 35 | Breast | Invasive/infiltrating ductal carcinoma | II | T3N1M0 | Malignant |
| E4 | 52 | F | 39 | Breast | Invasive/infiltrating ductal carcinoma | II | T4N2M0 | Malignant |
| E5 | 53 | F | 50 | Breast | Invasive/infiltrating ductal carcinoma | II~III | T2N1M0 | Malignant |
| E6 | 54 | F | 44 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| E7 | 55 | F | 55 | Breast | Invasive/infiltrating ductal carcinoma | II | T3N2M0 | Malignant |
| E8 | 56 | F | 30 | Breast | Invasive/infiltrating lobular carcinoma | II | T2N1M0 | Malignant |
| E9 | 57 | F | 39 | Breast | Invasive/infiltrating lobular carcinoma | II | T2N1M0 | Malignant |
| E10 | 58 | F | 41 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| E11 | 59 | F | 47 | Breast | Invasive/infiltrating lobular carcinoma | II | T4N1M0 | Malignant |
| E12 | 60 | F | 50 | Breast | Invasive/infiltrating ductal carcinoma | II | T3N1M0 | Malignant |
| F1 | 61 | F | 35 | Lymph node | Lymph node metastasis of E01 | Metastasis | ||
| F2 | 62 | F | 40 | Lymph node | Lymph node metastasis of E02 | Metastasis | ||
| F3 | 63 | F | 35 | Lymph node | Lymph node metastasis of E03 | Metastasis | ||
| F4 | 64 | F | 39 | Lymph node | Lymph node metastasis of E04 | Metastasis | ||
| F5 | 65 | F | 50 | Lymph node | Lymph node metastasis of E05 | Metastasis | ||
| F6 | 66 | F | 44 | Lymph node | Lymph node metastasis of E06 | Metastasis | ||
| F7 | 67 | F | 55 | Lymph node | Lymph node metastasis of E07 | Metastasis | ||
| F8 | 68 | F | 30 | Lymph node | Lymph node metastasis of E08 | Metastasis | ||
| F9 | 69 | F | 39 | Lymph node | Lymph node metastasis of E09 | Metastasis | ||
| F10 | 70 | F | 41 | Lymph node | Lymph node metastasis of E10 | Metastasis | ||
| F11 | 71 | F | 47 | Lymph node | Lymph node metastasis of E11 | Metastasis | ||
| F12 | 72 | F | 50 | Lymph node | Lymph node metastasis of E12 | Metastasis | ||
| G1 | 73 | F | 38 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| G2 | 74 | F | 42 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| G3 | 75 | F | 42 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| G4 | 76 | F | 69 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| G5 | 77 | F | 45 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| G6 | 78 | F | 54 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| G7 | 79 | F | 40 | Breast | Invasive/infiltrating ductal carcinoma | III | T2N1M0 | Malignant |
| G8 | 80 | F | 68 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| G9 | 81 | F | 37 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| G10 | 82 | F | 50 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| G11 | 83 | F | 42 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| G12 | 84 | F | 54 | Breast | Invasive/infiltrating ductal carcinoma | II | T2N1M0 | Malignant |
| H1 | 85 | F | 38 | Lymph node | Lymph node metastasis of G01 | Metastasis | ||
| H2 | 86 | F | 42 | Lymph node | Lymph node metastasis of G02 | Metastasis | ||
| H3 | 87 | F | 42 | Lymph node | Lymph node metastasis of G03 | Metastasis | ||
| H4 | 88 | F | 69 | Lymph node | Lymph node metastasis of G04 | Metastasis | ||
| H5 | 89 | F | 45 | Lymph node | Lymph node metastasis of G05 | Metastasis | ||
| H6 | 90 | F | 54 | Lymph node | Lymph node metastasis of G06 | Metastasis | ||
| H7 | 91 | F | 40 | Lymph node | Lymph node metastasis of G07 | Metastasis | ||
| H8 | 92 | F | 68 | Lymph node | Lymph node metastasis of G08 | Metastasis | ||
| H9 | 93 | F | 37 | Lymph node | Lymph node metastasis of G09 | Metastasis | ||
| H10 | 94 | F | 50 | Lymph node | Lymph node metastasis of G10 | Metastasis | ||
| H11 | 95 | F | 42 | Lymph node | Lymph node metastasis of G11 | Metastasis | ||
| H12 | 96 | F | 54 | Lymph node | Lymph node metastasis of G12 | Metastasis |
*For precise diagnosis, refer to pathology description.
カートに商品を
追加しました。
追加しました。
ヒト組織アレイのFAQ
カートに商品を
追加しました。
追加しました。
製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。